Comparison of immune response by virus infection and vaccination to 2009 pandemic influenza A/H1N1 in children

Journal of Korean Medical Science

Volumn 28, Issue 2, 2013, Pages 274-279

  Kang, Eun Kyeong ^a   Lim, Jung Sub ^b   Lee, Jun Ah ^b   Kim, Dong Ho ^a,b  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

Author keywords

Child; Immune response; Natural infection; Pandemic influenza A; Vaccination

Indexed keywords

NEUTRALIZING ANTIBODY;

ADOLESCENT; ANTIBODY PRODUCTION; ARTICLE; BLOOD; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; METABOLISM; NATURAL INFECTION; PANDEMIC; PANDEMIC INFLUENZA A; PRESCHOOL CHILD; VACCINATION;

CHILD; IMMUNE RESPONSE; NATURAL INFECTION; PANDEMIC INFLUENZA A; VACCINATION;

ADOLESCENT; ANTIBODIES, NEUTRALIZING; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; VACCINATION;

EID: 84874796533     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.2.274     Document Type: Article

References (24)

1. CDC. Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 400-2.
2. CDC. Outbreak of swine origin influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 467-70.
3. Kreijtz JH, Fouchier RA, Rimmelzwaan GF. Immune responses to influenza virus infection. Virus Res 2011; 162: 19-30.
4. Demicheli V, Jefferson T, Rivetti D, Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000; 18: 957-1030.
5. Broberg E, Nicoll A, Amato-Gauci A. Seroprevalence to influenza A (H1N1) 2009 virus: where are we? Clin Vaccine Immunol 2011; 18: 1205-12.
6. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375: 1100-8.
7. Kim JH, Yoo HS, Lee JS, Lee EG, Park HK, Sung YH, Kim S, Kim HS, Shin SY, Lee JK. The spread of pandemic H1N1 2009 by age and region and the comparison among monitoring tools. J Korean Med Sci 2010; 25: 1109-12.
8. Von Kries R, Weiss S, Falkenhorst G, Wirth S, Kaiser P, Huppertz HI, Tenenbaum T, Schroten H, Streng A, Liese J, et al. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (Swine flu) among children <18 years in Germany. PLoS One 2011; 6: e23955.
9. Korea Centers for Disease Control and Prevention. Current status of selected infectious diseases. Public Health Wkly Rep 2009; 2: 886.
10. WHO. WHO manual on animal influenza diagnosis and surveillance. Available at: www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev. pdf. [accessed on 27 Nov 2011]
11. Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull 1979; 35: 69-75.
12. Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, Lambert S, Nissen M, Marshall H, Booy R, Heron L, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants and children: a randomized trial. JAMA 2010; 303: 37-46.
13. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010; 375: 41-8.
14. Oh CE, Lee J, Kang JH, Hong YJ, Kim YK, Cheong HJ, Ahn YJ, Kim SH, Lee HJ. Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial. Vaccine 2010; 28: 5857-63.
15. Fiore AE, Neuzil KM. 2009 influenza A (H1N1) monovalent vaccines for children. JAMA 2010; 303: 73-4.
16. Walter EB, Rajagopal S, Zhu Y, Neuzil KM, Fairchok MP, Englund JA. Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally? Vaccine 2010; 28: 4376-83.
17. Wright P. Influenza viruses. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia, PA: Saunders, 2007, p1384-6.
18. Takahashi E, Kataoka K, Fujii K, Chida J, Mizuno D, Fukui M, Hiro-O Ito, Fujihashi K, Kido H. Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus. Microbes Infect 2010; 12: 778-83.
19. Li IW, Hung IF, To KK, Chan KH, Wong SS, Chan JF, Cheng VC, Tsang OT, Lai ST, Lau YL, et al. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 2010; 137: 759-68.
20. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361: 1945-52.
21. Jackson ML, France AM, Hancock K, Lu X, Veguilla V, Sun H, Liu F, Hadler J, Harcourt BH, Esposito DH, et al. Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave-New York City, April-May 2009. Clin Infect Dis 2011; 53: 455-62.
22. Chao DY, Cheng KF, Hsieh YH, Li TC, Wu TN, Chen CY, Tsai CA, Chen JH, Chiu HT, Lu JJ, et al. Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A (H1N1) vaccine. Vaccine 2011; 29: 617-23.
23. Choi YS, Baek YH, Kang W, Nam SJ, Lee J, You S, Chang DY, Youn JC, Choi YK, Shin EC. Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination. Clin Vaccine Immunol 2011; 18: 1519-23.
24. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010; 7: e1000258.